Hemodialysis for an unusual occurrence of leptospirosis in a nonendemic region.
Leptospira semaranga
acute kidney injury
leptospirosis
refugee
Journal
Hemodialysis international. International Symposium on Home Hemodialysis
ISSN: 1542-4758
Titre abrégé: Hemodial Int
Pays: Canada
ID NLM: 101093910
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
16
03
2023
received:
12
02
2023
accepted:
20
03
2023
medline:
21
7
2023
pubmed:
4
4
2023
entrez:
3
4
2023
Statut:
ppublish
Résumé
Leptospirosis, an endemic zoonotic disease caused by Leptospira, is frequently seen in tropical regions and areas with low socioeconomic status. The disease can present a range of symptoms from mild to fatal, with potential involvement of multiple organs. This case report describes the treatment and clinical course of a 44-year-old male patient infected with Leptospira semeranga patoc 1 and presenting with jaundice and renal failure. The patient was residing in the Syrian Refugee Camp in the arid city of Sanliurfa. This case serves as an example of a nonendemic occurrence of leptospirosis, and a brief overview of relevant literature on the subject is also provided.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
E33-E36Informations de copyright
© 2023 International Society for Hemodialysis.
Références
Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17:494-501.
Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296-326.
Meites E, Jay MT, Deresinski S, Shieh WJ, Zaki SR, Tompkins L, et al. Reemerging leptospirosis, California. Emerg Infect Dis. 2004;10:406-12.
Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008;12:351-7.
Mohd Hanapi IR, Sahimin N, Maackara MJB, Annisa AS, Mutalib RNSA, Lewis JW, et al. Prevalence of anti-Leptospira antibodies and associated risk factors in the Malaysian refugee communities. BMC Infect Dis. 2021;21:1-11.
Karande S, Gandhi D, Kulkarni M, Bharadwaj R, Pol S, Thakare J, et al. Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002. J Trop Pediatr. 2005;51:174-81.
de Jesus MS, Silva LA, Lima KM d S, Fernandes OCC. Cases distribution of leptospirosis in City of Manaus, state of Amazonas, Brazil, 2000-2010. Rev Soc Bras Med Trop. 2012;45:713-6.
Reis RB, Ribeiro GS, Felzemburgh RDM, Santana FS, Mohr S, Melendez AXTO, et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis. 2008;2:e228.
Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat AC, et al. Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis. 2013;7:e1991.
Vanasco NB, Schmeling MF, Lottersberger J, Costa F, Ko AI, Tarabla HD. Clinical characteristics and risk factors of human leptospirosis in Argentina (1999-2005). Acta Trop. 2008;107:255-8.
Yang H-Y, Hsu P-Y, Pan M-J, Wu M-S, Lee C-H, Yu C-C, et al. Clinical distinction and evaluation of leptospirosis in Taiwan-a case-control study. J. Nephrol. 2005;18:45-53.
von Ranke FM, Zanetti G, Hochhegger B, Marchiori E. Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review. Lung. 2013;191:9-18.
Rathinam SR, Rathnam S, Selvaraj S, Dean D, Nozik RA, Namperumalsamy P. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol. 1997;124:71-9.
Bandara AGNMK, Kalaivarny G, Perera N, Indrakumar J. Aseptic meningitis as the initial presentation of Leptospira borgpetersenii serovar Tarassovi: two case reports and a literature review. BMC Infect Dis. 2021;21:1-6.
Pappachan MJ, Mathew S, Aravindan KP, Khader A, Bharghavan PV, Kareem MM, et al. Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India. 2004;17:240-2.
Gasem MH, Hadi U, Alisjahbana B, Tjitra E, Hapsari MMDEAH, Lestari ES, et al. Leptospirosis in Indonesia: diagnostic challenges associated with atypical clinical manifestations and limited laboratory capacity. BMC Infect Dis. 2020;20:1-11.
Limmathurotsakul D, Turner EL, Wuthiekanun V, Thaipadungpanit J, Suputtamongkol Y, Chierakul W, et al. Fool's gold: why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis. 2012;55:322-31.
Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis. 2003;36:447-52.
Tiengrim S, Peacock SJ, Wuthiekanun V, Suputtamongkol Y, Day NP, Apiwattanaporn A, et al. The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am J Trop Med Hyg. 2009;81:695-7.
Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis. 2001;33:1834-41.
Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev. 2012;CD008264. https://doi.org/10.1002/14651858.CD008264.pub2